Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850107944123760640 |
|---|---|
| author | Charles Pei Zeinab El Boghdadly Lisa Blackburn Nidhi Sharma Naresh Bumma Abdullah M. Khan Srinivas Devarakonda Elvira Umyarova Don Benson Ashley Rosko Francesca Cottini |
| author_facet | Charles Pei Zeinab El Boghdadly Lisa Blackburn Nidhi Sharma Naresh Bumma Abdullah M. Khan Srinivas Devarakonda Elvira Umyarova Don Benson Ashley Rosko Francesca Cottini |
| author_sort | Charles Pei |
| collection | DOAJ |
| format | Article |
| id | doaj-art-7ae35c04e2a1461ab548220a183191eb |
| institution | OA Journals |
| issn | 2950-3280 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Neoplasia |
| spelling | doaj-art-7ae35c04e2a1461ab548220a183191eb2025-08-20T02:38:29ZengElsevierBlood Neoplasia2950-32802025-08-012310009710.1016/j.bneo.2025.100097Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamabCharles Pei0Zeinab El Boghdadly1Lisa Blackburn2Nidhi Sharma3Naresh Bumma4Abdullah M. Khan5Srinivas Devarakonda6Elvira Umyarova7Don Benson8Ashley Rosko9Francesca Cottini10Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OHDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH; Correspondence: Francesca Cottini, Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, 385G Wiseman Hall, 400 W 12th Ave, Columbus, OH 43210-1240;http://www.sciencedirect.com/science/article/pii/S2950328025000329 |
| spellingShingle | Charles Pei Zeinab El Boghdadly Lisa Blackburn Nidhi Sharma Naresh Bumma Abdullah M. Khan Srinivas Devarakonda Elvira Umyarova Don Benson Ashley Rosko Francesca Cottini Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab Blood Neoplasia |
| title | Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab |
| title_full | Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab |
| title_fullStr | Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab |
| title_full_unstemmed | Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab |
| title_short | Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab |
| title_sort | risk factors and clinical impact of cytomegalovirus dnaemia in patients with multiple myeloma treated with teclistamab |
| url | http://www.sciencedirect.com/science/article/pii/S2950328025000329 |
| work_keys_str_mv | AT charlespei riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT zeinabelboghdadly riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT lisablackburn riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT nidhisharma riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT nareshbumma riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT abdullahmkhan riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT srinivasdevarakonda riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT elviraumyarova riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT donbenson riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT ashleyrosko riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab AT francescacottini riskfactorsandclinicalimpactofcytomegalovirusdnaemiainpatientswithmultiplemyelomatreatedwithteclistamab |